Targeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what’s new and what’s enough

por Zhou, Fei, Zhou, Cai-Cun
Publicado 2015

Immunotherapy in non-small cell lung cancer: advancements and challenges

por Zhou, Fei, Zhou, Cai-Cun
Publicado 2021

Atypical chemokine receptor D6 inhibits human non-small cell lung cancer growth by sequestration of chemokines

por WU, FENG YING, FAN, JIANG, TANG, LIANG, ZHAO, YIN MIN, ZHOU, CAI CUN
Publicado 2013

Prophylactic Cranial Irradiation May Impose a Detrimental Effect on Overall Survival of Patients with Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis

por Xie, Shuan-shuan, Li, Ming, Zhou, Cai-cun, Song, Xiao-lian, Wang, Chang-hui
Publicado 2014

Mosquito coil exposure associated with small cell lung cancer: A report of three cases

por ZHANG, JIE, QI, HUI-WEI, SUN, YU-PING, XIE, HUI-KANG, ZHOU, CAI-CUN
Publicado 2015

Integrin β1-mediated acquired gefitinib resistance in non-small cell lung cancer cells occurs via the phosphoinositide 3-kinase-dependent pathway

por DENG, QIN-FANG, SU, BO, ZHAO, YIN-MIN, TANG, LIANG, ZHANG, JIE, ZHOU, CAI-CUN
Publicado 2016

Differences in Immunological Landscape between EGFR-Mutated and Wild-Type Lung Adenocarcinoma

por Luo, Jia-Wei, Guo, Yan-Hua, Wu, Feng-Ying, Li, Xue-Fei, Sun, Xue-Cheng, Wang, Jia-Lu, Zhou, Cai-Cun
Publicado 2021

A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study

por Xiong, An-Wen, Fang, Jue-Min, Ren, Sheng-Xiang, Li, Wei, Wang, Jing, Zhao, Yu, Chen, Guo-You, Xu, Qing, Zhou, Cai-Cun
Publicado 2021

Transition from Ambrisentan to Bosentan in Pulmonary Arterial Hypertension: A Single-Center Prospective Study

por Gong, Su-Gang, Wang, Lan, Pudasaini, Bigyan, Yuan, Ping, Jiang, Rong, Zhao, Qin-Hua, He, Jing, Zhang, Rui, Wu, Wen-hui, Liu, Jin-Ming, Zhou, Cai-cun
Publicado 2018

Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD‐L1‐positive locally advanced or metastatic non–small‐cell lung cancer:...

por Wu, Yi‐Long, Zhang, Li, Fan, Yun, Zhou, JianYing, Zhang, Li, Zhou, Qing, Li, Wei, Hu, ChengPing, Chen, GongYan, Zhang, Xin, Zhou, CaiCun, Dang, Thao, Sadowski, Sara, Kush, Debra A., Zhou, Yu, Li, Ben, Mok, Tony
Publicado 2020

A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung c...

por Liu, Ke-Jun, Guan, Zhong-Zhen, Liang, Ying, Yang, Xu-Qing, Peng, Jin, Huang, He, Shao, Qing-Xiang, Wang, Meng-Zhao, Zhu, Yun-Zhong, Wu, Chang-Ping, Wang, Shao-Bin, Xiong, Jian-Ping, Bai, Yu-Xian, Yu, Shi-Ying, Zhang, Yang, Hu, Xiao-Hua, Feng, Ji-Feng, Wu, Shi-Xiu, Jiao, Shun-Chang, Zhou, Cai-Cun, Wang, Jie, Wu, Hai-Ying
Publicado 2014

Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study

por Zhou, Qing, Zhang, He-Long, Jiang, Li-Yan, Shi, Yuan-Kai, Chen, Yuan, Yu, Jin-Ming, Zhou, Cai-Cun, He, Yong, Hu, Yan-Ping, Liang, Zong-An, Pan, Yue-Yin, Zhuo, Wen-Lei, Song, Yong, Wu, Gang, Chen, Gong-Yan, Lu, You, Zhang, Cui-Ying, Zhang, Yi-Ping, Cheng, Ying, Lu, Shun, Wang, Chang-Li, Zhou, Jian-Ying, Liu, Yun-Peng, He, Jian-Xing, Wang, Jie, Wu, Yi-Long
Publicado 2023